Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.

Autor: Heudel PE; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France. PierreEtienne.heudel@lyon.unicancer.fr.; Leon Berard Cancer Center, 28 Rue Laënnec, Cedex 08, 69373, Lyon, France. PierreEtienne.heudel@lyon.unicancer.fr., Fervers B; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Durand T; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Chabaud S; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Michallet AS; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Gomez F; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Rivoire M; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Bachelot T; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Claude L; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Chassagne-Clement C; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Pilleul F; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Mognetti T; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Russias B; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Soubirou JL; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Chvetzoff G; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Pérol D; Leon Berard Cancer Center, 28 Rue Laennec, 69008, Lyon, France., Blay JY; Leon Berard Cancer Center, Claude Bernard University of Lyon I, 28 Rue Laennec, 69008, Lyon, France.
Jazyk: angličtina
Zdroj: International journal of clinical oncology [Int J Clin Oncol] 2021 Oct; Vol. 26 (10), pp. 1793-1804. Date of Electronic Publication: 2021 Jun 05.
DOI: 10.1007/s10147-021-01963-3
Abstrakt: Background: Second primary cancers (SPC) account for 18% of all cancers. We used the enhanced medical/health data mining tool ConSoRe to search aggregated data, analyze electronic patient records (EPR), and better characterize patients with SPC.
Methods: This retrospective cohort study used ConSoRe to identify EPRs from patients with SPC referred to the regional cancer center Leon Bérard from 1993 to 2017, and examined characteristics of patients with SPC, frequencies of first primary cancer (FPC) localization in the global population of patients with SPC, and time to SPC. Data set was extracted on January 1, 2018.
Results: Among 296,530 EPRs, we identified 157,187 patients with FPC, including 13,002 (8%) patients with SPC. Between 2000 and 2010, the rate of SPC was 34%, and 52% of SPC were identified in the last years (2010-2017). In men, main cancers were head and neck cancer, lymphoma, and prostate carcinoma accounting for 15.6%, 12.8%, and 10.5% of FPC, while the three most common SPC were head and neck cancer (13.2%), lung cancer (11.8%) and lymphoma (9.2%). In women, breast cancers, lymphoma, and skin cancers accounted for 48.8%, 8%, and 5.1% of first cancers, and for 31.1%, 7% and 6% of SPC.
Conclusion: The data mining tool ConSoRe contributes to access to real world data, and to better characterize patients with SPC. Expanding such approach to any comprehensive center will allow a global overview of the follow-up of patients with cancer, and help to improve long-term management and adapt surveillance.
(© 2021. Japan Society of Clinical Oncology.)
Databáze: MEDLINE
Externí odkaz: